Literature DB >> 8757601

Chemokine expression by intraepithelial gamma delta T cells. Implications for the recruitment of inflammatory cells to damaged epithelia.

R Boismenu1, L Feng, Y Y Xia, J C Chang, W L Havran.   

Abstract

T cells expressing gamma delta TCR may have evolved to recognize Ag in a different manner as well as perform a broader set of functions than T cells with alpha beta TCR. In this study, we tested the hypothesis that dendritic epidermal T cells (DETC) bearing the invariant V gamma 3V delta 1 TCR may be able to signal the migration of peripheral alpha beta T cells to the epidermis by secreting specific chemokines. Expression of macrophage inflammatory protein (MIP)-1 alpha, MIP-1 beta, RANTES, and lymphotactin was inducible in DETC 7-17 cells, whereas mRNA for monocyte chemoattractant protein (MCP)-1 could not be detected. Strikingly, lymphotactin was the most abundant chemokine produced by activated DETC 7-17 cells. Activated primary DETC cultures also produced copious amounts of lymphotactin mRNA. Similarly, freshly isolated and activated intestinal intraepithelial T cells (i-IEL) with gamma delta TCR expressed high levels of lymphotactin mRNA. In contrast, lymphotactin mRNA was present in activated spleen gamma delta T cells at low basal levels. Migration of CD8+ T cells induced by culture supernatants from stimulated DETC 7-17 cells was strongly reduced in the presence of a neutralizing anti-lymphotactin antiserum and to a lesser extent by neutralizing anti-MIP-1 alpha, anti-MIP-1 beta, or anti-RANTES antiserum. The presence of lymphotactin in supernatants from activated DETC 7-17 cultures was directly demonstrated by Western blot analysis. These observations are consistent with a model in which gamma delta IEL play an active multi-faceted role in the maintenance of epithelia homeostasis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757601

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  71 in total

1.  CD8+ T cells have an essential role in pulmonary clearance of nontypeable Haemophilus influenzae following mucosal immunization.

Authors:  A R Foxwell; J M Kyd; G Karupiah; A W Cripps
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 2.  Interleukin 12 and innate molecules for enhanced mucosal immunity.

Authors:  P N Boyaka; J W Lillard; J McGhee
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 3.  A role for epithelial gammadelta T cells in tissue repair.

Authors:  W L Havran
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 4.  Function of intestinal gammadelta T cells.

Authors:  R Boismenu
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 5.  A role for epithelial gamma delta T cells in tissue repair.

Authors:  D A Witherden; S E Rieder; R Boismenu; W L Havran
Journal:  Springer Semin Immunopathol       Date:  2000

Review 6.  Intraepithelial gamma delta T lymphocytes: sentinel cells at mucosal barriers.

Authors:  D A Ferrick; D P King; K A Jackson; R K Braun; S Tam; D M Hyde; B L Beaman
Journal:  Springer Semin Immunopathol       Date:  2000

Review 7.  gamma delta T cells in autoimmunity.

Authors:  Z Yin; J Craft
Journal:  Springer Semin Immunopathol       Date:  2000

8.  Exaggerated proinflammatory and Th1 responses in the absence of gamma/delta T cells after infection with Listeria monocytogenes.

Authors:  M J Skeen; E P Rix; M M Freeman; H K Ziegler
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

9.  Attributes of gammadelta intraepithelial lymphocytes as suggested by their transcriptional profile.

Authors:  A M Fahrer; Y Konigshofer; E M Kerr; G Ghandour; D H Mack; M M Davis; Y H Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

Review 10.  IL-17+ γδ T cells as kick-starters of inflammation.

Authors:  Pedro H Papotto; Julie C Ribot; Bruno Silva-Santos
Journal:  Nat Immunol       Date:  2017-05-18       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.